Reduced-intensity haploidentical peripheral blood stem cell transplantation using low-dose thymoglobulin for aggressive adult T cell leukemia/lymphoma patients in non-complete remission

Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) has been accepted as a treatment option for aggressive (acute or lymphoma type) adult T cell leukemia/lymphoma (ATLL) patients with a poor prognosis, when a suitable HLA-matched donor is not available. However, haplo-HSCT carries a...

Descripción completa

Detalles Bibliográficos
Autores principales: Hirosawa, Makoto, Yamaguchi, Takahiro, Tanaka, Aya, Kominato, Yoshihiko, Higashi, Takehiro, Morimoto, Hiroaki, Tsukada, Junichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060159/
https://www.ncbi.nlm.nih.gov/pubmed/32006150
http://dx.doi.org/10.1007/s00277-020-03934-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060159/
https://www.ncbi.nlm.nih.gov/pubmed/32006150
http://dx.doi.org/10.1007/s00277-020-03934-6

Ejemplares similares